首页> 外文期刊>Hepatitis Monthly >CLINICAL FEATURES AND LONG TERM OUTCOME OF 102 TREATED AUTOIMMUNE HEPATITIS PATIENTS
【24h】

CLINICAL FEATURES AND LONG TERM OUTCOME OF 102 TREATED AUTOIMMUNE HEPATITIS PATIENTS

机译:102例自动免疫性肝炎患者的临床特点和长期预后

获取原文
           

摘要

Background: There is limited data on the natural history of autoimmune hepatitis (AIH) and on the long-term follow-up of AIH patients who have been referred for regular medical attention.Objectives: We evaluated the clinical presentation and natural history of AIH in a large cohort of type I AIH patients from Iran.Patients and Methods: Between 1997 and 2008, 102 patients were enrolled in the study.Patients were diagnosed using the International Autoimmune Hepatitis Group criteria and were followed up for an average of 60 months. Clinical and biochemical data were gathered from all the patients at both the beginning and the end of the follow-up period.Liver biopsy was performed in all patients before treatment, and the biopsies were performed in 28 patients after treatment.Results: Biochemical remission was achieved by 80 (79.4%) patients. Of these, 53 (66.5%) showed near-normal liver histology or liver function test results and sonogram. The remaining 27 (33.5%) patients also achieved clinical and biochemical remission, but developed compensated cirrhosis. After a period of remission, 24 patients (32.5%) relapsed.Among the 22 (21.6%) patients who showed ultimate treatment failure, 6 underwent orthotopic liver transplantation and 3 died of liver failure while awaiting a transplant. Sixteen (72.7%) of the 22 patients who did not respond to therapy were non-compliant with medications and had irregular follow-up. The overall 10-year survival rate in the cohort was 96%.Conclusions: Long-term survival in AIH patients is very good. Prompt diagnosis and appropriate first-line and salvage therapy that includes close follow-up will make liver transplantation a rare necessity in the treatment of this disease.
机译:背景:关于自身免疫性肝炎(AIH)的自然病史和已接受常规医疗救助的AIH患者的长期随访的数据有限。目的:我们评估了AIH患者的临床表现和自然病史患者和方法:1997年至2008年,该研究招募了102名患者,并根据国际自身免疫性肝炎小组的标准对患者进行了诊断,平均随访60个月。随访期间开始和结束时均收集所有患者的临床和生化数据,治疗前对所有患者进行肝活检,治疗后对28例患者进行活检。 80位患者(79.4%)达到了这一目标。其中53例(66.5%)的肝组织学或肝功能检查结果及超声检查结果接近正常。其余27名(33.5%)患者也达到了临床和生化缓解,但发展为代偿性肝硬化。缓解一段时间后,复发24例(32.5%),其中22例(21.6%)显示出最终治疗失败,其中6例进行了原位肝移植,3例在等待移植时因肝衰竭死亡。对治疗无反应的22例患者中有16例(72.7%)不服药且随访不规律。该队列的总体10年生存率为96%。结论:AIH患者的长期生存非常好。及时的诊断以及包括密切随访的适当一线和挽救疗法将使肝移植成为该疾病治疗中不可或缺的必要条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号